Asset Management
Compare Stocks
5 / 10Stock Comparison
NEWT vs HONE vs NBTB vs EGBN vs TRMK
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
NEWT vs HONE vs NBTB vs EGBN vs TRMK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $394M | $522M | $2.35B | $799M | $2.64B |
| Revenue (TTM) | $322M | $314M | $867M | $634M | $1.12B |
| Net Income (TTM) | $61M | $26M | $169M | $-128M | $224M |
| Gross Margin | 75.3% | 50.9% | 72.1% | 3.2% | 71.0% |
| Operating Margin | 42.5% | 10.9% | 25.3% | -26.9% | 25.5% |
| Forward P/E | 5.9x | 13.3x | 10.8x | 15.7x | 11.5x |
| Total Debt | $823M | $517M | $327M | $147M | $1.12B |
| Cash & Equiv. | $284M | $231M | $185M | $12M | $668M |
NEWT vs HONE vs NBTB vs EGBN vs TRMK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NewtekOne, Inc. (NEWT) | 100 | 79.7 | -20.3% |
| HarborOne Bancorp, … (HONE) | 100 | 151.8 | +51.8% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Eagle Bancorp, Inc. (EGBN) | 100 | 81.0 | -19.0% |
| Trustmark Corporati… (TRMK) | 100 | 188.7 | +88.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEWT vs HONE vs NBTB vs EGBN vs TRMK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEWT is the #2 pick in this set and the best alternative if valuation efficiency and bank quality is your priority.
- PEG 0.72 vs NBTB's 1.53
- NIM 3.8% vs HONE's 2.2%
- Lower P/E (5.9x vs 11.5x), PEG 0.72 vs 1.42
- 8.0% yield, 1-year raise streak, vs NBTB's 3.2%
HONE is the clearest fit if your priority is growth exposure.
- Rev growth 10.7%, EPS growth 78.4%
NBTB ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- Lower volatility, beta 0.89, Low D/E 17.3%, current ratio 1.60x
- Beta 0.89, yield 3.2%, current ratio 1.60x
- Beta 0.89 vs NEWT's 1.69, lower leverage
EGBN carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.3% vs NBTB's 0.5% (lower = leaner)
- +46.7% vs HONE's +7.9%
- Efficiency ratio 0.3% vs NBTB's 0.5%
TRMK is the clearest fit if your priority is long-term compounding.
- 127.7% 10Y total return vs NEWT's 142.9%
- 34.8% NII/revenue growth vs EGBN's -10.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs EGBN's -10.4% | |
| Value | Lower P/E (5.9x vs 11.5x), PEG 0.72 vs 1.42 | |
| Quality / Margins | Efficiency ratio 0.3% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.89 vs NEWT's 1.69, lower leverage | |
| Dividends | 8.0% yield, 1-year raise streak, vs NBTB's 3.2% | |
| Momentum (1Y) | +46.7% vs HONE's +7.9% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NBTB's 0.5% |
NEWT vs HONE vs NBTB vs EGBN vs TRMK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
NEWT vs HONE vs NBTB vs EGBN vs TRMK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NEWT leads in 2 of 6 categories
TRMK leads 1 • HONE leads 0 • NBTB leads 0 • EGBN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NEWT and NBTB each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
TRMK is the larger business by revenue, generating $1.1B annually — 3.6x HONE's $314M. TRMK is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to EGBN's -20.2%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $322M | $314M | $867M | $634M | $1.1B |
| EBITDAEarnings before interest/tax | $96M | $37M | $241M | -$168M | $323M |
| Net IncomeAfter-tax profit | $61M | $26M | $169M | -$128M | $224M |
| Free Cash FlowCash after capex | -$405M | $46M | $225M | -$6M | $230M |
| Gross MarginGross profit ÷ Revenue | +75.3% | +50.9% | +72.1% | +3.2% | +71.0% |
| Operating MarginEBIT ÷ Revenue | +42.5% | +10.9% | +25.3% | -26.9% | +25.5% |
| Net MarginNet income ÷ Revenue | +18.8% | +8.7% | +19.5% | -20.2% | +20.0% |
| FCF MarginFCF ÷ Revenue | +17.3% | +0.8% | +25.2% | +3.3% | +20.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +11.8% | +11.1% | +39.5% | -50.0% | +5.4% |
Valuation Metrics
NEWT leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 5.8x trailing earnings, NEWT trades at a 68% valuation discount to HONE's 18.3x P/E. Adjusting for growth (PEG ratio), NEWT offers better value at 0.70x vs NBTB's 1.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $394M | $522M | $2.4B | $799M | $2.6B |
| Enterprise ValueMkt cap + debt − cash | $933M | $808M | $2.5B | $935M | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 5.79x | 18.33x | 13.53x | -6.23x | 12.13x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.93x | 13.30x | 10.80x | 15.73x | 11.50x |
| PEG RatioP/E ÷ EPS growth rate | 0.70x | 1.23x | 1.92x | — | 1.50x |
| EV / EBITDAEnterprise value multiple | 6.79x | 20.84x | 10.35x | — | 9.49x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 1.66x | 2.71x | 1.26x | 2.36x |
| Price / BookPrice ÷ Book value/share | 0.88x | 0.87x | 1.21x | 0.69x | 1.28x |
| Price / FCFMarket cap ÷ FCF | 7.05x | 200.70x | 10.75x | 38.50x | 11.39x |
Profitability & Efficiency
NEWT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NEWT delivers a 17.3% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-11 for EGBN. EGBN carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to NEWT's 2.07x. On the Piotroski fundamental quality scale (0–9), NBTB scores 7/9 vs EGBN's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.3% | +4.6% | +9.5% | -10.9% | +10.8% |
| ROA (TTM)Return on assets | +2.6% | +0.5% | +1.1% | -1.2% | +1.2% |
| ROICReturn on invested capital | +9.2% | +2.3% | +7.9% | -8.2% | +7.1% |
| ROCEReturn on capital employed | +13.6% | +3.5% | +2.4% | -2.9% | +3.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 7 | 4 | 7 |
| Debt / EquityFinancial leverage | 2.07x | 0.90x | 0.17x | 0.13x | 0.53x |
| Net DebtTotal debt minus cash | $539M | $285M | $142M | $135M | $448M |
| Cash & Equiv.Liquid assets | $284M | $231M | $185M | $12M | $668M |
| Total DebtShort + long-term debt | $823M | $517M | $327M | $147M | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | 1.10x | 0.24x | 1.05x | -0.51x | 0.75x |
Total Returns (Dividends Reinvested)
TRMK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TRMK five years ago would be worth $14,756 today (with dividends reinvested), compared to $5,901 for EGBN. Over the past 12 months, EGBN leads with a +46.7% total return vs HONE's +7.9%. The 3-year compound annual growth rate (CAGR) favors TRMK at 29.8% vs NEWT's 10.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.3% | — | +9.3% | +25.8% | +15.5% |
| 1-Year ReturnPast 12 months | +45.6% | +7.9% | +9.0% | +46.7% | +32.5% |
| 3-Year ReturnCumulative with dividends | +35.4% | +58.9% | +54.1% | +47.1% | +118.5% |
| 5-Year ReturnCumulative with dividends | -23.2% | -5.8% | +29.9% | -41.0% | +47.6% |
| 10-Year ReturnCumulative with dividends | +142.9% | +88.3% | +102.2% | -31.7% | +127.7% |
| CAGR (3Y)Annualised 3-year return | +10.6% | +16.7% | +15.5% | +13.7% | +29.8% |
Risk & Volatility
Evenly matched — NBTB and TRMK each lead in 1 of 2 comparable metrics.
Risk & Volatility
NBTB is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than NEWT's 1.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRMK currently trades 97.6% from its 52-week high vs HONE's 84.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.69x | 1.05x | 0.89x | 1.21x | 0.94x |
| 52-Week HighHighest price in past year | $14.91 | $14.29 | $46.92 | $29.26 | $45.99 |
| 52-Week LowLowest price in past year | $9.59 | $10.57 | $39.20 | $15.03 | $33.39 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +84.7% | +96.1% | +89.6% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 32.5 | 57.3 | 53.5 | 56.0 |
| Avg Volume (50D)Average daily shares traded | 205K | 0 | 236K | 281K | 392K |
Analyst Outlook
Evenly matched — NEWT and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NEWT as "Hold", HONE as "Hold", NBTB as "Hold", EGBN as "Hold", TRMK as "Hold". Consensus price targets imply 15.7% upside for HONE (target: $14) vs 1.4% for TRMK (target: $46). For income investors, NEWT offers the higher dividend yield at 8.00% vs EGBN's 1.93%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $14.00 | $14.00 | $46.00 | $28.67 | $45.50 |
| # AnalystsCovering analysts | 9 | 6 | 10 | 14 | 9 |
| Dividend YieldAnnual dividend ÷ price | +8.0% | +2.6% | +3.2% | +1.9% | +2.2% |
| Dividend StreakConsecutive years of raises | 1 | 5 | 12 | 0 | 1 |
| Dividend / ShareAnnual DPS | $1.09 | $0.32 | $1.43 | $0.51 | $0.97 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +4.1% | +0.4% | 0.0% | +3.0% |
NEWT leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). TRMK leads in 1 (Total Returns). 3 tied.
NEWT vs HONE vs NBTB vs EGBN vs TRMK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEWT or HONE or NBTB or EGBN or TRMK a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus -10. 4% for Eagle Bancorp, Inc. (EGBN). NewtekOne, Inc. (NEWT) offers the better valuation at 5. 8x trailing P/E (5. 9x forward), making it the more compelling value choice. Analysts rate NewtekOne, Inc. (NEWT) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEWT or HONE or NBTB or EGBN or TRMK?
On trailing P/E, NewtekOne, Inc.
(NEWT) is the cheapest at 5. 8x versus HarborOne Bancorp, Inc. at 18. 3x. On forward P/E, NewtekOne, Inc. is actually cheaper at 5. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NewtekOne, Inc. wins at 0. 72x versus NBT Bancorp Inc. 's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NEWT or HONE or NBTB or EGBN or TRMK?
Over the past 5 years, Trustmark Corporation (TRMK) delivered a total return of +47.
6%, compared to -41. 0% for Eagle Bancorp, Inc. (EGBN). Over 10 years, the gap is even starker: NEWT returned +142. 9% versus EGBN's -31. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEWT or HONE or NBTB or EGBN or TRMK?
By beta (market sensitivity over 5 years), NBT Bancorp Inc.
(NBTB) is the lower-risk stock at 0. 89β versus NewtekOne, Inc. 's 1. 69β — meaning NEWT is approximately 91% more volatile than NBTB relative to the S&P 500. On balance sheet safety, Eagle Bancorp, Inc. (EGBN) carries a lower debt/equity ratio of 13% versus 2% for NewtekOne, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NEWT or HONE or NBTB or EGBN or TRMK?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus -10. 4% for Eagle Bancorp, Inc. (EGBN). On earnings-per-share growth, the picture is similar: HarborOne Bancorp, Inc. grew EPS 78. 4% year-over-year, compared to -169. 9% for Eagle Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEWT or HONE or NBTB or EGBN or TRMK?
Trustmark Corporation (TRMK) is the more profitable company, earning 20.
0% net margin versus -20. 2% for Eagle Bancorp, Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEWT leads at 42. 5% versus -26. 9% for EGBN. At the gross margin level — before operating expenses — NEWT leads at 75. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEWT or HONE or NBTB or EGBN or TRMK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NewtekOne, Inc. (NEWT) is the more undervalued stock at a PEG of 0. 72x versus NBT Bancorp Inc. 's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NewtekOne, Inc. (NEWT) trades at 5. 9x forward P/E versus 15. 7x for Eagle Bancorp, Inc. — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HONE: 15. 7% to $14. 00.
08Which pays a better dividend — NEWT or HONE or NBTB or EGBN or TRMK?
All stocks in this comparison pay dividends.
NewtekOne, Inc. (NEWT) offers the highest yield at 8. 0%, versus 1. 9% for Eagle Bancorp, Inc. (EGBN).
09Is NEWT or HONE or NBTB or EGBN or TRMK better for a retirement portfolio?
For long-horizon retirement investors, NBT Bancorp Inc.
(NBTB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 3. 2% yield, +102. 2% 10Y return). NewtekOne, Inc. (NEWT) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NBTB: +102. 2%, NEWT: +142. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEWT and HONE and NBTB and EGBN and TRMK?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEWT is a small-cap deep-value stock; HONE is a small-cap quality compounder stock; NBTB is a small-cap deep-value stock; EGBN is a small-cap quality compounder stock; TRMK is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.